9th Annual Outsourcing in Clinical Trials DACH

Stand Number: 10b

We are delighted to announce we will be attending the 9^th Annual Outsourcing in Clinical Trials DACH.

This event provides a specific platform for the clinical trials community in the German, Austrian, and Swiss regions to develop innovative clinical operations and outsourcing strategies. At this event, Bedfont^® will be exhibiting the innovative NObreath^® Fractional Exhaled Nitric Oxide (FeNO) device. The NObreath^® FeNO device has been improving asthma management for over 15 years.

Trusted by clinicians across the globe, NObreath^® brings proven, patient friendly FeNO testing to clinical research: simply accurately and without compromise. Conforming to the joint NICE/BTS/SIGN, ATS and ERS guidelines, the NObreath^® is a powerful tool to aid in the diagnosis and management of asthma. Be sure to drop by stand 10b from Tuesday, 3^rd November to Wednesday, 4^th November to meet the team!